Pesticidal compositions and processes related thereto
US-9215870-B2 · Dec 22, 2015 · US
US2017165290A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017165290-A1 |
| Application number | US-201615340082-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 1, 2016 |
| Priority date | Oct 27, 2011 |
| Publication date | Jun 15, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are compounds and compositions characterized, in certain embodiments, by conjugation of various groups, such as lipophilic groups, to an amino or amide group of an amino acid, a linear or cyclic peptide, a linear or cyclic polypeptide, or structural isomer thereof, to provide compounds of the present invention, collectively referred to herein as “APPLs”. Such APPLs are deemed useful for a variety of applications, such as, for example, improved nucleotide delivery. Exemplary APPLs include, but are not limited to, compounds of Formula (I), (II), (III), (IV), (V), and (VI), and salts thereof, as described herein: wherein m, n, p, R′, R 1 , R 2 , R 3 , R 4 , R 5 , R 8 , Z, W, Y, and Z are as defined herein.
Opening claim text (preview).
1 . A method of delivering a polynucleotide to a cell, the method comprising contacting a composition comprising a polynucleotide and a compound of Formula (III): or salt thereof, with the cell under conditions sufficient to facilitate delivery of the polynucleotide into the interior of the cell; wherein: p is an integer of between 1 and 9, inclusive; each instance of Q is independently O, S, or NR Q , wherein R Q is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, a nitrogen protecting group, or a group of the formula (i), (ii), (iii); each instance of R 1 is independently hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, halogen, —OR A1 , —N(R A1 ) 2 , —SR A1 , or a group of formula (iv); wherein each occurrence of R A1 is independently hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, an oxygen protecting group when attached to an oxygen atom, a sulfur protecting group when attached to an sulfur atom, a nitrogen protecting group when attached to a nitrogen atom, or two R A1 groups are joined to form an optionally substituted heterocyclic or optionally substituted heteroaryl ring, provided at least one instance of R 1 is a group of formula: L is optionally substituted alkylene, optionally substituted alkenylene, optionally substituted alkynylene, optionally substituted heteroalkylene, optionally substituted heteroalkenylene, optionally substituted heteroalkynylene, optionally substituted carbocyclylene, optionally substituted heterocyclylene, optionally substituted arylene, or optionally substituted heteroarylene; R 6 and R 7 are each independently hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, a nitrogen protecting group, or a group of the formula (i), (ii), or (iii); each instance of R 2 is independently hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, a nitrogen protecting group, or a group of the formula (i), (ii), or (iii); Formulae (i), (ii), and (iii) are: wherein each instance of formula (i) is independently formula (i-a) or formula (i-b): each instance of R′ is independently hydrogen or optionally substituted alkyl; X is O, S, or NR X , wherein Rx is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, or a nitrogen protecting group; Y is O, S, or NR Y , wherein R Y is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, or a nitrogen protecting group; R P is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, an oxygen protecting group when attached to an oxygen atom, a sulfur protecting group when attached to a sulfur atom, or a nitrogen protecting group when attached to a nitrogen atom; and R L is optionally substituted C 6-50 alkyl, optionally substituted C 6-50 alkenyl, optionally substituted C 6-50 alkynyl, optionally substituted heteroC 6-50 alkyl, optionally substituted heteroC 6-50 alkenyl, optionally substituted heteroC 6-50 alkynyl, or a polymer; provided that at least one instance of R Q , R 2 , R 6 , or R 7 is a group of the formula (i), (ii), or (iii). 2 . (canceled) 3 . The method of claim 1 , wherein each instance of Q is O. 4 . The method of claim 1 , wherein at least one instance of R 2 is hydrogen. 5 . The method of claim 1 , wherein each instance of R 1 is a group of formula (iv). 6 . The method of claim 1 , wherein L is an optionally substituted alkylene. 7 . The method of claim 1 , wherein the group of formula (iv) is of formula: wherein q is an integer between 1 and 50, inclusive. 8 - 10 . (canceled) 11 . The method of claim 1 , wherein the compound is selected from the group consisting of: and salts thereof, wherein: R 1 is selected from the group consisting of —H, —CH 3 , —CH(CH 3 ) 2 , —CH(CH 3 )(CH 2 CH 3 ), —CH 2 CH(CH 3 ) 2 , provided at least one R 1 is a group of formula: and R 6 and R 7 are each independently selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, a nitrogen protecting group when attached to a nitrogen atom, an oxygen protecting group when attached to an oxygen atom, a sulfur protecting group when attached to a sulfur atom, and a group of formula (i), (ii), or (iii). 12 . The method of claim 1 , wherein the compound is selected from the group consisting of:
Antineoplastic agents · CPC title
Drugs for immunological or allergic disorders · CPC title
Immunosuppressants, e.g. drugs for graft rejection · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.